1Pretorius M, Rosenbaum D,Vaughan DE. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin [J]. Circulation, 2003 Feb 4;107(4):579
2Papakonstantinou E, Roth M, Kokkas B, et al. Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrixdeposition by primary human vascular smooth muscle cells [J]. J Cardiovasc Pharmacol, 2001 Nov;38(5):715
3Li-Saw-Hee FL, Beevers DG, Lip GY. Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial [J]. Int J Cardiol, 2001 May;78(3):241
4Erdem-Y, Usalan-C, Haznedaroglu-IC, et al. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension [J]. Am J Hypertens, 1999 Nov; 12(11 Pt 1): 1071
5Fogari R, Zoppi A, Preti P, et al. Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women [J]. Am J Hypertens, 2001 Sep;14(9 Pt 1):921
6Sayer JW, Gutteridge C, Syndercombe-Court D, et al. Circadian activity of the endogenous fibrinolytic system in table coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors [J]. J Am Coll Cardiol, 199
7De Luca N, Izzo R, Fontana D, et al. Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine [J]. J Hypertens, 2000 Oct;18(10):1515
8Gleerup G, Petersen JR, Mehlsen J, et al. Effects of spirapril and hydrochlorothiazide on platelet function and euglobulin clotlysis time in patients with mild hypertension [J]. Angiology,1996;47:951
9Pahor M, Franse LV, Deitcher SR,et al. Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1 [J]. Circulation, 2002 Jan 29;105(4):457
10Brown NJ, Vaughan DE. ACEinhibition decreases PAI-1 in the seting of an activatedRAS(abst) [J]. Hypertension,1996;27:1299
